Bioadaptives, Inc. SEC filings BDPT
Bioadaptives, Inc. has 176 filings in SEC EDGAR's recent list, going back to May 3, 2013. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Mar 28, 2025 | Mar 28, 2025 |
| DEF 14C | Information statement | Mar 14, 2025 | Mar 14, 2025 |
| DEF 14C | Information statement | Mar 28, 2023 | Mar 27, 2023 |
| PRE 14C | Pre14c | Mar 9, 2023 | Mar 8, 2023 |
| DEF 14C | Information statement | Mar 15, 2022 | Mar 14, 2022 |
| PRE 14C | Filing | Jan 27, 2022 | Jan 26, 2022 |
| DEF 14C | Information statement | Mar 4, 2020 | Mar 2, 2020 |
| PRE 14C | Filing | Feb 10, 2020 | Feb 7, 2020 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BDPT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1575142
- Former names
- APEX 8 Inc. (until Aug 19, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.